BaickerKTaubmanSLAllenHL. The Oregon experiment—effects of Medicaid on clinical outcomes. N Engl J Med. 2013;368(18):1713-1722.
2.
BrauerCANeumannPJRosenAB. Trends in cost effectiveness analyses in orthopaedic surgery. Clin Orthop Relat Res. 2007;457:42-48.
3.
BrophyRHWrightRWMatavaMJ. Cost analysis of converting from single-bundle to double-bundle anterior cruciate ligament reconstruction. Am J Sports Med. 2009;37(4):683-687.
4.
ChiouCFHayJWWallaceJF. Development and validation of a grading system for the quality of cost-effectiveness studies. Med Care. 2003;41(1):32-44.
GenuarioJWDoneganRPHammanDBellJE. The cost-effectiveness of single-row compared with double-row arthroscopic rotator cuff repair. J Bone Joint Surg Am. 2012;94(15):1369-1377.
10.
GenuarioJWFaucettSCBoublikMSchlegelTF. A cost-effectiveness analysis comparing 3 anterior cruciate ligament graft types: bone–patellar tendon–bone autograft, hamstring autograft, and allograft. Am J Sports Med. 2012;40(2):307-314.
11.
GuyattGHFeenyDHPatrickDL. Measuring health-related quality of life. Ann Intern Med. 1993;118(8):622-629.
12.
HadornDC. Setting health care priorities in Oregon: cost-effectiveness meets the rule of rescue. JAMA. 1991;265(17):2218-2225.
13.
HarrisJ. QALYfying the value of life. J Med Ethics. 1987;13(3):117-123.
14.
KassirerJPAngellM. The Journal’s policy on cost-effective analyses. N Engl J Med. 1994;331(10):669-670.
NwachukwuBUHamidKSBozicKJ. Measuring value in orthopaedic surgery. JBJS Rev. 2013;1(2):e2.
17.
NwachukwuBUSchairerWWBernsteinJLDodwellERMarxRGAllenAA. Cost-effectiveness analyses in orthopaedic sports medicine: a systematic review. Am J Sports Med. 2015;43(6):1530-1537.
18.
OberlanderJ. Health reform interrupted: the unraveling of the Oregon Health Plan. Health Aff (Millwood). 2007;26(1):w96-w105.
19.
OfmanJJSullivanSDNeumannPJ. Examining the value and quality of health economic analyses: implications of utilizing the QHES. J Manag Care Pharm. 2003;9(1):53-61.
20.
PerryPAHotzeT. Oregon’s experiment with prioritizing public health care services. Virtual Mentor. 2011;13(4):241-247.
21.
RussellLBGoldMRSiegelJDanielsNWeinsteinMC. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996;276(14):1172-1177.
22.
SamuelsonEMBrownDE. Cost-effectiveness analysis of autologous chondrocyte implantation: a comparison of periosteal patch versus type I/III collagen membrane. Am J Sports Med. 2012;40(6):1252-1258.
23.
ShawJWJohnsonJACoonsSJ. US Valuation of the EQ-5D health states. Development and testing of the D1 valuation model. Med Care. 2005;43(3):203-220.
24.
SiegelJEWeinsteinMCRussellLBGoldMR. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996;276:1339-1341.
25.
SlevinMLPlantHLynchDDrinkwaterJGregoryWM. Who should measure quality of life, the doctor or the patient?Br J Cancer. 1988;57(1):109-112.
26.
WeinsteinMCSiegelJEGoldMRKamletMSRussellLB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA. 1996;276(15):1253-1258.
